DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

ImmunoGen (NASDAQ: IMGN)

8.93 0.04 (0.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $8.93 0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.87
Previous Close $8.89
Daily Range $8.81 - $9.11
52-Week Range $5.34 - $13.78
Market Cap $769.6M
P/E Ratio -13.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,096,441
Average Daily Volume 1,351,314
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

Why ImmunoGen Inc. Shares Tumbled Today

After reporting first-quarter financials Friday, ImmunoGen Inc.'s shares fell despite bullish analyst reports.

The 5 Winners and Losers From ASCO Presentations

Immunogen (IMGN) Showing Signs Of Perilous Reversal Today

Credit Suisse Analysts Assume Coverage On 10 Biotech Stocks

Mixed Bag for ImmunoGen Inc.

Pipeline progressing but with some setbacks mixed in.

ImmunoGen's (IMGN) CEO Dan Junius Q3 2015 Results - Earnings Call Transcript

Health Care Sector Update for 04/24/2015: IMGN, GWPH, AZN

ImmunoGen (IMGN) Q1 2015 Results - Earnings Call Webcast

Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog

Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog

See More IMGN News...

IMGN's Top Competitors

IMGN $8.93 (0.45%)
Current stock: IMGN
AMGN $159.01 (-2.79%)
Current stock: AMGN
GILD $109.77 (-1.74%)
Current stock: GILD
BIIB $392.88 (-1.45%)
Current stock: BIIB